1. Executive Summary (Confidence: High)

Korify Capital is a strategic financier in the global longevity ecosystem, managing the $100 million "Korify Capital Fund ONE".^[18] The firm invests in Series A–C rounds, specifically targeting companies that address the biological drivers of aging and the low response rates of traditional mental health treatments.^[18] Korify’s investment thesis is centered on "Maintaining health and preventing illness," utilizing AI and genomics to accelerate drug discovery.^[18] With "anchor" investments in Cambrian Biopharma and Alto Neuroscience, Korify has demonstrated a track record of identifying future market leaders, including companies that have achieved successful public listings.^[18]